A half a node or a whole node: A comparison of methods for submitting lymph nodes

American Journal of Clinical Pathology

Volumn 109, Issue 5, 1998, Pages 571-576

  Niemann, Theodore H ^a,b   Yilmaz, Asli G ^a   Marsh Jr , William L ^a   Lucas, Joel G ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b E 403 Doan Hall ^*  (United States)

Author keywords

Cost analysis; Lymph node sampling

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COST BENEFIT ANALYSIS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAMPLING;

EID: 0031918881     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.5.571     Document Type: Article

References (32)

1. Mitka M. Physician pay back up, but two-year trend still shows loss. Am Med News. 1997;40:1,26.
2. AMA Physician Marketplace statistics 1994: Hours in Professional Activities per Week 1994. Chicago, Ill: American Medical Association; 1994.
3. Castleberry BM, Wargelin L. 1996 wage and vacancy survey of medical laboratories. Lab Med. 1997;28:176-180.
4. Beahrs OH, Henson DE, Hutter RVP, et al. Manual for Staging of Cancer. 4th ed. Philadelphia, Pa: Lippincott; 1992.
5. Fowble B, Gray R, Gilchrist K, et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol. 1988;6:1107-1117.
6. Durkin K, Haagensen CD. An improved technique for the study of lymph nodes in surgical specimens. Ann Surg. 1980;191:419-429.
7. Hartveit F, Samsonsen G, Tangen M, et al. Routine histological investigation of the axillary nodes in breast cancer. Clin Oncol. 1982:8:121-126.
8. Schmitz-Moorman P, Thomas C, Pohl C, et al. Patho-anatomical demonstration of lymph node metastases in a surgical specimen. Pathol Res Pract. 1982;174:403-111.
9. Morrow M, Evans J, Rosen PP, et al. Does clearing of axillary lymph nodes contribute to accurate staging of breast carcinoma? Cancer. 1984;53:1329-1332.
10. Kingsley WB, Peters GN, Cheek JH. What constitutes adequate study of axillary lymph nodes in breast cancer? Ann Surg. 1985;201:311-314.
11. Saphir O, Amromin GD. Obscure axillary lymph-node metastasis in carcinoma of the breast. Cancer. 1948;1:238-241.
12. Pickren JW. Significance of occult metastases. Cancer. 1961;14:1266-1271.
13. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978;42:2025-2031.
14. Rosen PP, Saigo PE, Braun DW Jr, et al. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli. Am J Surg Pathol 1982;6:639-641.
15. Apostolikas N, Petraki C, Agnantis NJ. The reliability of histologically negative axillary lymph nodes in breast cancer. Pathol Res Pract. 1989;184:35-38.
16. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
17. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 1993;80:459-463.
18. Nasser IA, Lee AKC, Bosari S, et al. Occult axillary lymph node metastases in 'node-negative' breast carcinoma. Hum Pathol. 1993;24:950-957.
19. Wilkinson EJ, Hause LL, Kuzma JF, et al. Occult axillary lymph node metastasis in patients with invasive breast carcinoma. Lab Invest. 1981;44:83A.
20. Wells CA, Heryet A, Brochier J, et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer. 1984;50:193-197.
21. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987;55:516-520.
22. Sedmak DD, Meineke TA, Knechtges DS, et al. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2;516-520.
23. Raymond WA, Leong A S-Y. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer. Pathology. 1989;21:11-15.
24. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer. 1994;73:563-569.
25. Cochran AJ, Wen D-R, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. Am J Surg Pathol. 1988;12:612-618.
26. Heller R, Becker J, Wasselle J, et al. Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg. 1991;126:1455-1460.
27. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer. 1994;74:1595-1600.
28. Wilkinson EJ, Hause L. Probability in lymph node sectioning. Cancer. 1974:33:1269-1274.
29. Lester SC, Richardson A, Rushing L. The effects of routine methods of processing lymph nodes on the number of metastases detected in women with breast cancer. Mod Pathol. 1996;9:19A.
30. Schmidt WA. Principles and Techniques of Surgical Pathology. Reading, Mass: Addison-Wesley; 1983.
31. Rosai J. Ackerman's Surgical Pathology. St Louis, Mo: Mosby; 1996.
32. Hruban RH, Westra WH, Phelps TH, et al. Surgical Pathology Dissection: An Illustrated Guide. New York, NY: Springer; 1996.